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The Editorial on the Research Topic
Role of Stem Cells in Skeletal Muscle Development, Regeneration, Repair, Aging, and Disease
Skeletal muscle is a highly dynamic and plastic tissue, able to modify its intrinsic size or strength
following electric impulse, mechanical loading, or diet. Several muscular dystrophic disorders have
been characterized but the development of therapies, although promising, is still at an early phase.
Muscle dysfunction is not restricted to dystrophic patients; during aging, there is a gradual loss of
muscle function that results in a significant negative impact on the individual’s health, increasing
fall and lesion risks, loss of mobility and independence, and associated elevation of morbidity and
mortality. This loss of muscle has an estimated prevalence between 5 and 13% among 60–70 year
old individuals, increasing to 11–50% in those over the age of 80 (Morley, 2008). According to the
WHO, the expected number of individuals over 65 years old by the year 2050 will be around 1.5
billion (WHO, 2015); by extrapolation, this suggests that over 150 million patients will suffer from
muscle wasting disorders associated with aging.
The vertiginous development of the stem cell therapy and cellular reprogramming fields will
eventually result in the emergence of cell replacement therapies to treat a wide range of pathologies.
In skeletal muscle, the satellite cell—long regarded as a heterogeneous cell population—is
intimately linked to muscle physiology and regeneration processes (Chang and Rudnicki, 2014;
Dayanidhi and Lieber, 2014; Snijders et al.). The activation of these muscle-specific stem cells
is essential for injury healing, maintenance of muscle strength and tone, and delayed onset of
age-related sarcopenia.
In this issue, eight review and eight original research articles on this Research Topic summarize
recent progress and current challenges of the muscle biology field in aging and disease.
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ROLE OF STEM CELLS IN SKELETAL
MUSCLE DEVELOPMENT
Stem cells have a key role during the sequential stages of
embryonic muscle development, as demonstrated through many
decades of work using a multitude of animal models (Brand
Saberi, 2015). In this issue, Knight and colleagues develop a
novel pax7a:eGFP transgenic zebrafish injury-model in which
they demonstrate quantitatively that migration of GFP+ cells
upon injury depends on the specific characteristics of the induced
damage and on the embryonic developmental stage (Knappe
et al.). This suggests that muscle-resident pax7a-expressing cells
may function differently depending on experimental conditions;
unraveling these diverse functions represents a challenge and
has important implications for muscle repair and regeneration
studies.
Muscular dystrophies target head and trunk muscles
differently, indicating that satellite cells, which drive muscle
regeneration, may have molecular functional differences in each
muscle tissue. Dietrich and colleagues report on the regulation
of Pax7-expressing head muscle stem cells by comparing
chicken, mouse, frog and zebrafish models (Nogueira et al.).
They postulate a somewhat counterintuitive mechanism for
the emergence of craniofacial muscle stem cells, whereby de
novo expression of Pax7 is acquired later than the cellular
commitment to the myogenic fate, which is established
by expression of the myogenic regulatory factors (MRFs).
Guardiola and colleagues generate a novel mouse model to
better understand the importance of Cripto—a known regulator
of vertebrate embryogenesis—during postnatal skeletal muscle
regeneration (Prezioso et al.). When overexpressed in adult
satellite stem cells, Cripto promotes myogenic commitment and
fusion/differentiation in a time-dependent manner, improving
muscle regeneration upon acute injury. Availability of the
Tg:Criptomodel will be instrumental for the future development
of pharmacological approaches that target this important
pathway.
ROLE OF STEM CELLS IN SKELETAL
MUSCLE REGENERATION AND REPAIR
A number of epigenetic modifications are known to be key in
the regulation of satellite cell function (Giordani and Puri, 2013;
Dumont et al., 2015; Parker; Segales et al., 2015; Sousa-Victor
et al., 2015). Epigenetic marks on chromatin can be modified,
modulated, written and/or erased by the action of growth factors,
inflammatory signals, cellular redox status, developmental
pathway switches, and/or mechanical stimuli. The potential
reversibility of most of these epigenetic modifications provides an
attractive targeting approach for pharmacological manipulation.
Palacios and colleagues exhaustively review what is known about
the epigenetic impact of the signaling microenvironment upon
satellite cell chromatin during adult regenerative myogenesis
(Brancaccio and Palacios). Complementarily, Suelves and
colleagues reviewDNAmethylome (DNAmethylation signature)
dynamic changes during the processes of commitment and
differentiation of skeletal muscle, driven by the activation of the
MRFs, and address what is known about the methylome status in
pathological and aging processes (Carrio and Suelves).
Satellite cells are not the only stem cells residing in skeletal
muscle, and other progenitors and immune cell infiltrates can
influence this tissue’s regenerative potential (Burzyn et al.,
2013; Mozzetta et al., 2013; Pannerec et al., 2013; Farup
et al., 2015; Kostallari et al., 2015). Two articles in this issue
summarize the role of non-satellite stem cells in muscle biology
as well as their potential use in cell-based therapies. Delbono
and colleagues review the different roles of muscle-resident
perivascular cells in skeletal muscle physiology, defining two
distinctive types of pericytes. Their effects are linked—but not
limited—to positive outcomes, such as support for muscle
regeneration, reinnervation, and de-novo vessel formation and
negative outcomes, including unwanted differentiation, fibrosis,
fat accumulation, and heterotopic ossification (Birbrair et al.).
The article serves as a powerful warning for those eager to
push the early implementation of stem cell therapies, and
highlights the need to deepen our knowledge on the activation
and integration of transplanted stem cells, as these will not
contribute to the regeneration processes of the targeted organ in
all therapeutic approaches and could indeed be detrimental for
the patient.
In a distinct contribution, Forcales puts forward the case for
the closely related adipose-derived mesenchymal stem cell (ASC)
to be used for muscle regenerative therapies. The article presents
a collective view of ASC’s myogenic differentiation, engraftment
and functional assessment protocols as reported by different
research groups. Since these cells have shown good safety records
but poor efficacy when transplanted, the author advocates for
enhanced enrichment, expansion and manipulation of ASC-
derived myogenic progenitors to improve clinical outcomes.
ROLE OF STEM CELLS IN SKELETAL
MUSCLE AGING
Centenarians are the paradigm of healthy aging, and their
exceptional longevity and physical fitness must somehow be
related to genetic make-up. The identification of genetic
polymorphisms linked tomuscle mass and functionmaintenance
in the old age should be advantageous for the prevention
of age-related sarcopenia. In this long road, discarding many
potential candidates is also important. Lucia and colleagues
study the functional significance (i.e., whether they affect the
muscle transcriptional levels of the gene) of three candidate
SNPs in independent human cohorts. Although, they detect
correlation with transcriptional levels of the genes in close
proximity to the SNPs, they do not find association with
exceptional longevity (Fuku et al.). These findings are relevant
and intriguing because these SNPs, which are associated with
lean body mass, cardiorespiratory fitness and better physical
performance, nevertheless do not seem to be related necessarily
to an increase in longevity.
Another theoretical therapeutic approach gaining momentum
is directed toward the rejuvenation of the stem cell niche through
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its exposure to a “younger environment.” The identity of the
particular systemic factors mediating this promising therapeutic
possibility is under debate (Li and Izpisua Belmonte, 2014; Sinha
et al., 2014; Sousa-Victor et al., 2014, 2015; Brun and Rudnicki,
2015; Egerman et al., 2015; Rodgers and Eldridge, 2015).
Latella and colleagues provide an interesting review of some
recent breakthrough studies on cell-intrinsic vs. cell-extrinsic
mechanisms underlying satellite cell regenerative decline with
aging (Madaro and Latella). They advocate for new studies to
further explore the relationship between DNA damage, p38 and
p16INK4a signaling pathways on this age-associated decline.
The control of fibroblast growth factor (FGF) signaling
by Spry1 is altered with aging and affects satellite cell
quiescence maintenance (Chakkalakal et al., 2012; Tajbakhsh,
2013). Yablonka-Reuveni et al. show that only Fgfr1 and
Fgfr4 receptors are expressed in satellite cells; to better
understand their role in adult muscle regeneration upon
injury, the authors analyse the phenotype after Fgfr1 ablation.
They show that although FGF2-driven mitogenic response in
satellite cells is virtually absent, this does not affect muscle
regeneration, possibly due to the existence of compensatory
mechanisms.
ROLE OF STEM CELLS IN DISEASES OF
THE SKELETAL MUSCLE
Muscular dystrophies are among the most common and severe
diseases affecting skeletal muscle homeostasis and function.
While dystrophies share many common characteristics—most
being linked to the dystrophin-associated protein complex—a
distinct feature, used in diagnosis, is the differential effect of
the particular mutation on the various skeletal muscle groups.
Satellite stem cells are considered a notoriously heterogeneous
cell population (Motohashi and Asakura; Dumont et al., 2015).
Pavlath and colleagues review what is known on skeletal muscle
stem cell biology and compare satellite cells from eight different
muscle groups and the distinct extent of affection of the same
muscles in muscular dystrophies (Randolph and Pavlath). The
authors highlight the importance of further advancing our
knowledge on the biology of muscle derived satellite cells from
non-limb muscles, which have somehow been neglected until
now. Following this theme, Marazzi and colleagues analyze
variations on the support role provided by interstitial progenitor
cells (“PICs”) to muscle regeneration in an effort to further
characterize the satellite stem cell niche in extraocular muscles
(Formicola et al.). Interestingly, they observe an increase in
the number of PICs in both aged and dystrophic animals.
Because the maintenance of a high number of PICs positively
supports myogenesis, they conclude that that the extraocular-
specific increase of PIC numbers might underlie the resistance
to dystrophy by this muscle subset.
Biressi and Gopinath challenge the current thinking on the
connections between satellite stem cells and loss of muscle mass,
otherwise known as muscle wasting or atrophy. They review
the signaling pathways implicated and conclude that multiple
cause-related atrophies coexist within a single clinical entity
and that this may hinder the precise targeting required for the
development of novel therapeutic approaches.
Fittingly with the proposed topic, Lopez de Munain and
colleagues review the available evidence to classify Myotonic
dystrophy type 1 as a progeroid syndrome (Mateos-Aierdi et al.).
A number of the so-called “hallmarks of aging” (Lopez-Otin et al.,
2013) are detected in these patients whose disease is possibly
associated with satellite cell dysfunction. The article proposes
some of the research avenues that might be worth exploring in
the future.
Several microRNAs (miRs) have been implicated in muscle
stem cell function and homeostasis; their role on muscle
dysfunction and their associated disease has also been extensively
investigated (Rosales et al., 2013; Dey et al., 2014; Hindi and
Kumar, 2016). Musaró and colleagues locally overexpressed
the anabolic growth factor insulin-like growth factor 1 (IGF-
1) in Duchenne muscular dystrophy (mdx) muscle and studied
modulation of the miR signature, finding major changes in miR-
206 and miR-24 levels, that contributed to muscle differentiation
(Pelosi et al.). This research links the activation of anabolism
by the IGF-1 pathway in skeletal muscle with changes in
essential miRNA molecules never implicated in this process
before.
Finally, in McArdle disease, a genetic disorder of skeletal
muscle metabolism, patients struggle to perform resistance
exercise due to increased risk of severe rhabdomyolysis, which
may develop into acute tubular necrosis, renal failure, and severe
low blood pressure. In a clinical study, Lucia and colleagues
propose a novel resistance-training program in adult McArdle
patients that was well-tolerated according to clinical assessments.
The preliminary data support the possibility of a therapeutic
intervention involving regular participation in strength training
programs, with the potential to improve muscle mass, strength
and clinical outcome of McArdle patients (Santalla et al.).
FUTURE PROSPECTS
The field of skeletal muscle stem cell biology has exploded
in the past decade, although the advance experienced in our
knowledge of the function, origin, renewal, gene regulation,
epigenetics, aging, and senescence of these remarkable cells, only
represents a small step toward our full understanding of their
abilities and therapeutic potential. Many aspects of these cells
are still puzzling and would require a combined effort to unravel
their many secrets. We still lack comparative metabolomic and
transcriptomic analysis between cells of various origins and
muscle groups that may provide a more focused view on the
inherent properties of different muscles and their resistance
to disease; the explosion of single-cell “omic” approaches will
provide an unexpected wealth of new data and insight into
the biology of these cells. Another key area of present and
future development is to develop pharmacological or cell-based
therapeutic approaches to transcriptionally regulate satellite cells
so that they become amenable for clinical manipulation and
therapeutic deployment. In this quick journey from development
to adulthood, from regeneration to disease, we hope the reader
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finds some enlightenment on the multiple facets of satellite cell
biology, which is not free of discrepancies. In all, an increased
understanding of muscle biology makes us even more conscious
of the limits of our knowledge. Or, as Walt Whitman wrote “Do I
contradict myself? Very well, then, I contradict myself; (I am large-I
contain multitudes.).”
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